Skip to main content
Fig. 12 | BMC Medical Genomics

Fig. 12

From: Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma

Fig. 12

Exploring the immunotherapy in HCC patients. (A) Stromal and Immune cells scores in LIHC. (B) Comparison of the scores of TIDE between the high-risk and low-risk group. (C) The difference of PD-1 between the high-risk and low-risk group. (D) The difference of CTLA-4 between the high-risk and low-risk group. (E) The difference of PD-L1 between the high-risk and low-risk group

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us